StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / nucleome.com

Nucleome Therapeutics Limited

Nucleome Therapeutics Limited (nucleome.com): 1 change recorded in its website history since July 2022.

The website did not answer the latest live check. Last tried 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. MessagingBetween and
    BeforeDecoding the regulatory genome to deliver first-in-class precision medicines
    AfterTackling the root causes of disease hidden in our genome

    Classifier interpretation of website text.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 2 July 2022

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Decoding the dark matter of the human genome to uncover novel ways to treat disease

Decoding the dark matter of the human genome to uncover novel ways to treat disease Discover More

Homepage

Compliance claims on the website
GDPR

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. Seen February 2026 · 1 capture · latest observed messagingTackling the root causes of disease hidden in our genome

    This wording observed 6 February 2026.

    archived page
  2. July 2022 – January 2025 · 4 capturesDecoding the regulatory genome to deliver first-in-class precision medicines

    Decoding the regulatory genome to deliver first-in-class precision medicinesDiscover More Biotech TV interview with Nucleome CEO Mark Bodmer, September 2024 In a recent interview with Biotech TV, CEO

    This wording observed 9 January 2025.

    archived page
    Inspect 4 captures in this group
    • 2 July 2022 · Decoding the dark matter of the human genome to uncover novel ways to treat disease archived page
    • 26 September 2023 · Decoding the dark matter of the human genome to deliver first-in-class precision medicines archived page
    • 4 January 2024 · Decoding the dark matter of the human genome to deliver first-in-class precision medicines archived page
    • 9 January 2025 · Decoding the regulatory genome to deliver first-in-class precision medicines archived page
Summary of the record · AI-written

Written by an AI model on 7 November 2026 from the dated observations above; this is not the date the changes happened; each point links to the changes it rests on.

Nucleome Therapeutics updates homepage positioning

Nucleome Therapeutics has updated its homepage headline to emphasize tackling root causes of disease in the genome. This may indicate a refined way of describing its focus.

  • Between January 2025 and February 2026, Nucleome Therapeutics changed its homepage headline from “Decoding the regulatory genome to deliver first-in-class precision medicines” to “Tackling the root causes of disease hidden in our genome”. [1]
  • Reading: Between January 2025 and February 2026, a classifier read this change as a repositioning of how Nucleome Therapeutics presents its work on the genome and disease. [1]

Cite this record

StartupHistory, “Nucleome Therapeutics Limited” company record, https://startuphistory.org/c/nucleome.com

Machine-readable: /c/nucleome.com.json. How changes are found: method.